Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.430
-0.120 (-7.74%)
At close: Jun 5, 2026, 4:00 PM EDT
1.432
+0.002 (0.17%)
After-hours: Jun 5, 2026, 7:42 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $61.21 million as of June 5, 2026. Its market cap has increased by 69.74% in one year.
Market Cap
61.21M
Enterprise Value
-34.12M
1-Year Change
69.74%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $61.21M, a decrease of -73.97%. That is a compound annual growth rate of -31.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 61.21M | -19.52% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 69.76M |
| PDS Biotechnology | 68.10M |
| Veru Inc. | 67.89M |
| Filana Therapeutics | 67.63M |
| TScan Therapeutics | 66.66M |
| Seres Therapeutics | 66.33M |
| MediciNova | 64.97M |
| ImageneBio | 64.18M |